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ABSTRACT The occurrence of late-onset Alzheimer’s disease has been related to the lipid homeostasis. We tested whether the
membrane lipid environment affects the dynamics and cleavability of a model peptide corresponding to the amino acid sequence
684–726 of the amyloid precursor protein APP reconstituted in liposomes. Solid-state NMR with 2H-Ala713, which is located within
the putative transmembrane domain, suggested that the peptide observes less rotational motion in egg phosphatidylcholine (PhC)
membranes than in dimyristoyl-phosphatidylcholine (DMPC) bilayers above the main phase transition temperature Tc. The residue
15N-Ala692, which is in the vicinity of the a-cleavage site, i.e., Lys687, showed less motion after reconstitution in distearoyl-
phosphatidylcholine liposomes,Tc than in PhC, DMPC, or sphingomyelin vesicles. In all tested liposomal systems the a-cleavage
site was accessible for hydrolysis by trypsin. However, the catalytic rate constant was higher in the PhC and DMPC than in the
sphingomyelin and distearoyl-phosphatidylcholine systems. In conclusion, the dynamics of APP(684–726) on the transmembrane
level as well as the motion of the a-cleavage site and its hydrolysis by a model enzyme are dependent on the bilayer char-
acteristics. This could be relevant for the processing of APP in vivo.
INTRODUCTION
Alzheimer’s disease (AD) affects one-fourth to one-third of
the population aged 85 years or older in the Western world
(1). A hallmark of the disease is the deposition of b-amyloid
in the central nervous system. b-Amyloid peptides are gen-
erated by the membrane proteases b- and g-secretase from
the amyloid precursor protein (APP), a single span trans-
membrane protein of;770 amino acids. The positions of the
cleavage sites with respect to the putative transmembrane
domain of APP are shown in Fig. 1. The production of
b-amyloid is prevented by the membrane protease a-secretase
as it cleaves APP between the b- and g-cleavage sites. An
imbalance between the activities of the secretases and/or
between b-amyloid generation and its clearance from the
brain, leads to the development of the disease. Early-onset
AD, which usually presents in younger individuals, is clearly
linked to variations in the genes involved in the processing of
APP or in the APP gene itself (1).
The strongest risk factor for sporadic late-onset AD is age.
The intense search for genetic factors that increase the risk for
late-onset AD continues to bring polymorphisms that are
associated with the development of the disease to light (2,3).
The one which is best known and probably most frequently
involved in sporadic AD (4–6) is the APOE*4 allele of the
APOE gene, coding for the apolipoprotein ApoE, which is
involved in cholesterol homeostasis. The allele has an in-
creased occurrence among individuals with AD. Beside the
genetic risk factors there are dietary, environmental and life
style factors that were related to the disease (1). Several re-
ports put forward a link between dietary lipids and the inci-
dence of AD (7–10).
There is strong evidence from clinical, retrospective, animal,
and cell culture studies that the processing of APP is related
to the cholesterol homeostasis in the brain (8,11–18). Ac-
cording to one of the current models (11) high cholesterol
levels in the cell membrane promote the generation of
b-amyloid. However, some studies also show an increase in
b-amyloid production as a consequence of a moderate de-
pletion of cholesterol in neurons (19,20).
Beside cholesterol, other lipids were linked to the develop-
ment of AD. Oksman et al. (21) found an advantageous
effect, i.e., low b-amyloid levels in APP/PS1 transgenic
mice, of docosahexaenoic acid (DHA)-enriched diets but
observed increased levels of b-amyloid after a diet rich in
saturated fatty acids and cholesterol. DHA had a similar ef-
fect on APPsw transgenic mice (22). In general, the degree of
saturation of fatty acids and the position of the ﬁrst double
bond in essential fatty acids seem to be critical factors de-
termining the effect of dietary fats on the risk of AD. Un-
saturated fats and n-3 double bonds seem to confer protection
and an overabundance of saturated fats or n-6 double bonds
to increase the risk of developing AD (10). Another lipid that
deserves attention is sphingomyelin (Sph): a signiﬁcant in-
crease in its level has been reported in brains of AD patients
during the course of the disease (23).
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Lipids and their oxidation products could affect the APP
processing via different routes, including signaling functions,
regulation of transcription, and translation, or directly via
speciﬁc or unspeciﬁc interactions with the secretases, with
APP, or with b-amyloid. For instance, the activity of the
b-secretase BACE in hydrolyzing a soluble APP analog in a
liposomal assay was directly inﬂuenced by the lipid envi-
ronment of the enzyme (24). Lahdo et al. (25,26) showed that
the lipid composition of liposomes and lipid monolayers
determines their interactions with APP.
In this work, we focus on the a-cleavage site of APP
(Leu687/Lys688, Fig. 1). The nonamyloidogenic processing is
carried out by members of the ADAM family, i.e., disintegrin
and metalloproteases (27). The protein conformation of APP
in the vicinity of the a-cleavage site signiﬁcantly inﬂuences
the processing of APP. The introduction of an a-helix-
disturbing amino acid in position 692 (Ala/Gly, Ala/ Pro)
and 690 (Phe/ Pro; Fig. 1) increased the ratio of b-amyloid
to p3, the latter is the product of a- and g-cleavage of APP
(28). The variant APP Ala692Gly leads to familial AD and
cerebral hemorrhages (29).
We address the question whether the lipid composition of
the membrane environment of APP could inﬂuence the dy-
namics, accessibility and cleavability of APP at the a-cleavage
site. We incorporated the peptide APP(684–726), including
the putative transmembrane domain and the a-cleavage site,
into liposomes of different phosphocholine lipids. Fig. 1
shows part of APP including the tested peptide. The liposo-
mal system allows us to study the direct inﬂuence of the
membrane characteristics on APP, excluding indirect effects
that could occur in cellular systems.
Our studies were carried out with membranes consisting
of 1,2-dimyristoyl-sn-glycero-3-phosphocholine (DMPC),
1,2-distearoyl-sn-glycero-3-phosphocholine (DSPC), 1-palmitoyl-
2-oleoyl-sn-glycero-3-phosphocholine (POPC), egg phos-
phatidylcholine (PhC), and porcine brain Sph, respectively.
As shown in Table 1, these lipids differ mainly in their acyl
chain length and unsaturation, main phase transition tem-
perature Tc, and their backbone if comparing Sph to the
phosphatidylcholines.
The dynamics of the liposome-incorporated APP(684–726)
peptide was probed by solid-state NMR with 2H-Ala at po-
sition 713 and 15N-Ala at position 692, using magic angle
spinning (MAS). These positions are in the center of the
putative transmembrane domain and close to the a-cleavage
site, respectively (Fig. 1). In parallel, the accessibility and
cleavability of the a-cleavage site in the different membrane
environments were examined in a kinetic assay with trypsin,
which hydrolyses APP at the same position as a-secretase.
We found that the membrane composition has a signiﬁcant
inﬂuence on the motion of Ala692, which is in the vicinity of
the a-cleavage site, and that the unsaturation of the acyl
chains affects the dynamics of the transmembrane domain.
The model peptide was hydrolyzed by trypsin in all test
systems and Michaelis-Menten analysis showed that differ-
ences occurred from the catalytic step, possibly from the
release of the enzyme from the membrane surface.
METHODS
Chemicals
Fmoc-amino acids, Fmoc-Lys(Boc)-Wang resin (100–200 mesh, No. 04-12-
2057), and 5-carboxyﬂuorescein (5-FAM) (No. 01-63-0112) were purchased
from Merck Novabiochem (Darmstadt, Germany). Fmoc-PAL-PEG-resin
(0.19 mmol/g, No. GEN913383) was purchased from Applied Biosystems
FIGURE 1 APP sequence containing the putative transmembrane do-
main and the a-, b-, and g-cleavage sites. The amino acids are labeled
according to their physicochemical characteristics, i.e., acidic, basic, polar,
and hydrophobic. The gray background indicates the putative transmem-
brane domain. For NMR, APP(684–726) (box) was labeled with 2H and 15N
as indicated. Variants leading to Alzheimer’s disease are shown for amino
acids 692, 693, and 694. Amino acid counting according to APP770,
UniProtKB/Swiss-Prot entry P05067. The amino acid numbering of
b-amyloid (1–42) is indicated on the right of the amino acid labels.
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(Foster City, CA). Deuterium depleted water, Fmoc-alanine-3,3,3-D3
and Fmoc-alanine-15N derivatives were purchased from Cambridge Iso-
tope Laboratories (Andover, MA). Triﬂuoroacetic acid (TFA), 2,2,2-
triﬂuoroethanol (TFE), and hexaﬂuoro-2-propanol (HFIP) were from Fluka
(Buchs, Switzerland). The phospholipids DMPC, DSPC, POPC, and Sph
were fromAvanti Polar Lipids (Alabaster, AL). PhC grade 1 was supplied by
Lipid Products (Nutﬁeld, UK). All other chemicals were of analytical grade.
Synthesis of APP(684–726) and APP(684–687)
APP(684–726), H-His-His-Gln-Lys-Leu-Val-Phe-Phe-Ala-Glu-Asp-Val-Gly-
Ser-Asn-Lys-Gly-Ala-Ile-Ile-Gly-Leu-Met-Val-Gly-Gly-Val-Val-Ile-Ala-Thr-
Val-Ile-Val-Ile-Thr-Leu-Val-Met-Leu-Lys-Lys-Lys-NH2, and APP(684–687),
H-His-His-Gln-Lys-OH, were synthesized on an Applied Biosystems Peptide
Synthesizer Model 431. The peptides were synthesized on a 0.1 mmol scale
using standard Fastmoc protocols (30). PAL-PEG and Wang resin were used
for APP(684–726) and APP(684–687) yielding peptides with C-terminal
amides and acids respectively. Cleavage from the resin, and removal of pro-
tecting groups, was accomplished by treatment with TFA/water/ethane dithiol
(EDT)/triisopropylsilane (TIS) (volume ratios 94.5:2.5:2.5:1) for 4 h at room
temperature. The reaction mixture was ﬁltered and most of the TFA was
evaporated in an N2 stream. The peptide was then precipitated by adding cold
diethyl ether, collected by centrifugation and lyophilized from an aqueous TFE
10% (v/v) solution. The peptide purity was ;70% as conﬁrmed by reversed
phase HPLC (C4, Vydac 214TP54) and the peptide mass was conﬁrmed by
MALDI-TOF and ESI mass spectroscopy. The peptide was not further puriﬁed
as it accumulated on the HPLC column, resulting in low yields under all tested
conditions. For NMR studies 15N-Ala and CD3-Ala were introduced at posi-
tions 692 and 713, respectively.
Labeling of APP(684–726) and APP(684–687)
with 5-carboxyﬂuorescein
The coupling of 5-FAMwith APP(684–726) and APP(684–687) was carried
out according to Fischer et al. (31). Resin bound peptide was equilibrated
with a 20% (v/v) piperidine/dimethylformamide (DMF) solution before the
addition of a 10 mL DMF solution containing 5-FAM (2.5 eq), 2-(1H-9-
azabenzotriazole-1-yl)-1,1,3,3-tetramethyluronium hexaﬂuorophosphate
(HATU) (2.4 eq), and diisopropylethylamine (DIPEA) (5 eq). The reaction
was conducted in the dark for 16 h. The peptide-resins were washed several
times with 20% piperidine/DMF to remove the excess 5-FAM. The product
was cleaved as described for the untagged peptide and the purity and mo-
lecular weight conﬁrmed by reverse phase HPLC and MALDI-TOF and ESI
mass spectroscopy.
Preparation of APP(684–726)-liposomes
The peptides APP(684–726), 2H/15N-APP(684–726), and the ﬂuorescent
analog FAM-APP(684–726), respectively, were reconstituted into vesicles
of different lipid composition (Table 1). For the reconstitution of the peptides
in liposomes a protocol for the incorporation of hydrophobic peptides into
micelles (32) was adapted. Between 3 and 14 mg peptide was dissolved at a
concentration of 1 mg/mL in TFE and incubated for 2 h at room temperature
in the dark. The solution was then reduced to the volume of 1 mL in an N2
stream and added to the respective lipid solution in TFE (DMPC, DSPC, and
PhC) or HFIP (Sph) to reach a lipid/peptide molar ratio of 100:1. An excess
of water (;50 mL) was added to reconstitute the peptides into stable lipid
bilayers. Subsequently all solvent was removed by lyophilization, and the
dry powder was rehydrated with 4 mL 10 mM Tris, 1 mM EDTA, 130 mM
NaCl, pH 7.4 buffer (Tris/EDTA/NaCl) to form multilamellar vesicles
(MLV), which were submitted to 10 cycles of freeze and thaw (.Tc). For
NMR measurements, all solutions were prepared with 2H-depleted water.
Density gradient centrifugation was used to conﬁrm peptide incorporation
and sample homogeneity. The MLVwere therefore transferred with an equal
volume of 60% (w/v) sucrose in Tris/EDTA/NaCl into a 12.5 mL centrifuge
tube and overlaid with 2mL each of 20% (w/v), 10% (w/v), 5% (w/v) sucrose
and 1.5 mL buffer. After centrifugation at 200,0003 g for 19 h at 4C in an
SW41Ti rotor (Beckman Instruments, Fullerton, CA), MLVs containing the
peptide were visible as a clear band in the upper half of the tube. The density
of the liposomal fraction was calculated from the measured refractive index
(refractometer from Bellingham and Stanley, Turnbridge Wells, UK) ac-
cording to Birnie and Rickwood (33). The peptide-free control MLVs were
located on the top of the sucrose gradient, whereas MLVs containing peptide
were concentrated at higher densities, dependent on the type of lipid. DMPC,
DSPC, and Sph peptide MLV migrated to a density between 1.03 and 1.05
g/cm3. Peptide-containing PhC vesicles were visible in the upper part be-
tween 1.01 and 1.02 g/cm3.
The bands were collected and, after dilution in 10 mL buffer, pelleted
three times at 100,000 3 g for 1 h at 4C. Pelleted MLVs containing the
labeled peptide were used for NMR studies. For the circular dichroism (CD)
measurements and the tryptic cleavage assay, the pellets were resuspended in
buffer followed by 10 cycles of freeze and thaw (.Tc). Large unilamellar
vesicles (LUV)were prepared by subsequent extrusions through 0.8, 0.4, 0.2,
and 0.1 mm pore size polycarbonate membranes (Nucleopore, Whatman,
Brentford, UK) using the 10 mL extruder from Lipex Biomembranes
(Vancouver, Canada). The ﬁnal liposomes were characterized by dynamic
light scattering with a Zetasizer 3000 HSA (Malvern Instruments, Malvern,
UK). The hydrodynamic average mean diameters of all preparations were
between 130 and 170 nm (intensity distribution) with a polydispersity index
between 0.2 and 0.5, corresponding to a relative standard deviation between
40 and 70% assuming a monomodal size distribution. Quantiﬁcation of total
peptide was carried out with the DC protein assay kit from Bio-Rad
TABLE 1 Acyl chain composition and main transition temperature Tc of the investigated lipids
Lipid Acyl chains* Tc
y Hydrophobic thickness (nm)
DMPC 14:0 /14:0 23C 2.30 (La),z 2.62 (La),{ 2.9 (La)**
POPC 16:0 /18:1(C9-C10) 4C 2.58 (La)§
PhC 16:0 (34%), 18:1 (32%), 18:2 (18%) ,0C 2.71 (La){, 2.9 (La)**
DSPC 18:0 /18:0 54.5C 2.95 (La),yk 3.06 (La),** 3.60 (Lb)k
Sph 18:0 (49%), 24:1 (20%) 35C In the range of DSPC as judged from the acyl chain lengthsyy
*DMPC, DSPC, POPC, acyl chains at positions 1/2; PhC, Sph, major acyl chains with % occurrence in brackets.
yTc, main transition temperature from the gel (Lb) to the liquid-crystalline (La) phase according to Marsh (72) and Meyer et al. (73).
zLewis and Engelman (74).
§Nezil and Bloom (77).
{Nagle and Tristram-Nagle (75).
kRinia et al. (78).
**Cornell and Separovic (76).
yyNo data available.
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(Hercules, CA), which is based on the method of Lowry (34). Lipid con-
centrations were determined by TLC (35). The ﬁnal peptide/lipidmolar ratios
of peptide LUVs were between 1:100 and 1:200.
Solid-state NMR measurements
All NMR spectra were obtained on a Varian Inﬁnity1 500 spectrometer.
31P-NMR spectra were acquired with a 4 mm double resonance Varian T3
MAS probe using a Hahn-echo pulse sequence (36). 31P pulse lengths were
typically 8.0 ms with an inter pulse delay of 100 ms. During acquisition
continuous wave decoupling was used at moderate amplitude of 45 kHz to
prevent sample heating. A recycle delay of 2.5 sec was used and spectra are
the result of 1024 acquisitions. Before Fourier transform the data was left
shifted to the top of the echo and processed with 150 Hz linebroadening.
Deuterium and 15N measurements were carried out using a 6 mm double
resonance Varian T3 probe. Deuterium spectra were acquired with a 90
pulse of 5 ms and a recycle delay of 1 s. The spectra are a result of 128,000
acquisitions. Before Fourier transform the data were left shifted to the top of
the ﬁrst rotor echo to remove ﬁrst order phase distortions and a line-
broadening of 150 Hz was applied. Cross-polarization 15N spectra were
acquired where the protons were excited with a 5 ms pulse and the polari-
zation was subsequently transferred to 15N using an adiabatic cross-polari-
zation step with a spin-lock ﬁeld centered at 35 kHz (contact time 1 ms).
During acquisition 50 kHz TPPM (two pulse phase modulation) decoupling
was applied with a 10 phase shift. The recycle delay was 2 s and the spectra
are the sum of 64,000 acquisitions. A linebroadening of 150 Hz was applied
before Fourier transform.
Analysis of the NMR spectra
The spectra have been processed with Spinsight. The spinning sideband
pattern from the MAS experiments was analyzed according to the formalism
of Herzfeld and Berger (37). The intensities were calculated in C11 using
the GAMMA spin simulation package (38). Powder averaging was carried
out according to the method of Cheng et al. (39) using 1154 powder orien-
tations per 2H spectrum and 300 powder orientations in the case of 15N
spectra. The ﬁtting of the sideband intensities was carried out with the pro-
gram MINUIT (MINUIT, CERN Program Library Entry D506). The errors
given are those generated by MINUIT and represent 1 SD.
Circular dichroism measurements and analysis
All CD measurements were acquired with a JASCO J720 spectropolarimeter
attached to a NESLAB 111 bath circulator. CD spectra were obtained be-
tween 260 and 195 nm, with a 0.2 mmpath-length cell, a 20 nm/min scanning
speed, a response time of 4 s, and a bandwidth of 1 nm. The spectra reported
are the averages of four scans each, corrected by subtracting CD spectra of
the solvent or the liposomes without peptide. To estimate the secondary
structure contents of the peptide, the relevant CD spectra were analyzed with
the CDPro software (40). An extended reference set of 56 proteins was used,
which included spectra of 13 membrane proteins along with 43 soluble
proteins. The analysis was carried out with three deconvolution algorithms,
CONTIN/LL, CDSSTR, and SELCON3, in the wavelength range between
260 and 195 nm.
Tryptic cleavage assay
Fluorescent FAM-APP(684–726) was reconstituted in LUV of different lipid
composition as described above and subjected to proteolysis by trypsin.
Sequencing grade modiﬁed trypsin (Promega, Madison WI; Part No.
9PIV511, mw 23,400 (41)) was resuspended in Tris/EDTA/NaCl to a con-
centration of 0.1 mg/mL and incubated for 15 min at 37C. Of this enzyme
preparation, 11 mL were added to 1090 mL FAM-APP(684–726)/liposome
suspensions with peptide concentrations between 5 and 80 mM. The ﬁnal
enzyme to peptide molar ratio was #1:10,000 to ensure Michaelis-Menten
conditions. Kinetic experiments were carried out over 5 h at 37C. The re-
action was stopped at intervals of 1 h by the addition of 20mL of acidic buffer
(10 mM Tris, 1 mM EDTA, 130 mM NaCl, 1% (v/v) TFA) to 200 mL
sample. The peptide digests were analyzed by analytical HPLCwith a Vydac
214TP54 column (C4, 250 3 4.6 mm i.d., 5 mm particle size, 300 A˚ pore
size), which was equilibrated with 0.1% TFA-acetonitrile (9:1). The solvent
ﬂow rate was 1 mL min1, and the temperature was 40C. The samples (190
mL) were injected on the column and eluted under the initial conditions for 15
min before acetonitrile was increased in a linear gradient to 1:9 (v/v) within
15 min. The separation wasmonitored with a ﬂuorescence detector at lex 445
nm and lem 521 nm. The peak corresponding to the peptide fragment FAM-
APP(684–687) was identiﬁed by co-injection of the synthesized standard and
by ESI mass spectrometry. The amounts of the digested product FAM-
APP(684–687) were calculated from the integrated ﬂuorescent intensities of
a standard curve.
Michaelis-Menten analysis
The kinetics of trypsin cleavage were analyzed according to Michaelis-
Menten kinetics (Eqs. 1 and 2), which relate the reaction velocity v with the
Michaelis-Menten constant KM and the maximal velocity Vmax (Eq. 2 (42)).
E1 S%
k1
k1
ES/
kcat
E1 P11 P2: (1)
In Eq. 1, E denotes the enzyme, S the substrate, ES the enzyme-substrate
complex and P1 and P2 the products. The rate constants k1 and k1 determine
the afﬁnity between the substrate and the active site of the enzyme and kcat is
the rate constant of the catalytic step of the reaction, i.e., the hydrolysis itself
and the release of the products and the enzyme.
v ¼ Vmax3½FAM-APPð684-726Þ
KM1 ½FAM-APPð684-726Þ (2)
[FAM-APP(684–726)] in Eq. 2 denotes the molar concentration of FAM-
labeled substrate. Experimental data were analyzed according to Eq. 2 by
nonlinear regression with SigmaPlot v.9 from SPSS.
The rate constant kcat (Eq. 1) was calculated from Vmax according to Eq. 3:
kcat ¼ Vmax=½E; (3)
where [E] is the molar enzyme concentration, i.e., 5 3 1011 M.
RESULTS
Characterization of APP(684–726) MLVs
by 31P-NMR spectroscopy
The APP(684–726) MLV preparations were characterized by
31P-NMR to ascertain that the addition of the APP(684–726)
had not disrupted the lipid bilayer morphology or lead to
signiﬁcant changes in the phase behavior. At a lipid to protein
molar ratio of 100:1 and above the lipid Tc, all the
31P spectra
show an axially symmetric lineshape due to a chemical
shielding anisotropy (CSA) characterized by the anisotropy
parameter d of approximately 30 ppm and the asymmetry
h ¼ 0 (Fig. 2). This is characteristic of the lipids in their
liquid crystalline (La) phase (43). In the case of DMPC,
DSPC, and Sph, lowering the temperature below Tc resulted
in a broadening of the features in the spectra, characteristic
for the mobility of the lipids in the gel (Lb) phase (44). The
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spectra of the PhC and POPC (not shown) vesicles were
similar and showed a well-deﬁned, temperature-independent
31P line shape in the examined temperature range reﬂecting
the La phase of the membrane (Tc , 0C). These observa-
tions indicate that at the lipid to protein molar ratio of 100:1,
the APP(684–726) does not disrupt the bilayer morphology
or change signiﬁcantly the phase transition temperatures.
Characterization of reconstituted APP(684–726)
by circular dichroism
The conformation of solubilized APP(684–726) and of
APP(684–726) reconstituted in LUVs of different lipid
compositions was investigated by CD. CD spectra are shown
in Fig. 3 in the range between 195 and 260 nm that reﬂects the
secondary structural features of peptides. The multicompo-
nent analysis of the spectrum of APP(684–726) dissolved in
buffer containing 1% (v/v) acetonitrile indicated that the
peptide adopted predominantly b-strands and unordered
structures (Fig. 3, A and D).
Similar spectra and estimated structure characteristics
were found for APP(684–726) reconstituted in DSPC lipo-
somes, independent of the phase of the lipids (Fig. 3, C and
F). The CD spectra of APP(684–726) reconstituted in DMPC
and PhC LUVs, respectively (Fig. 3, A, B, and E), showed
typical features of partial a-helical structure, i.e., minima at
222 nm and at 208 nm (45). The analysis of these spectra
showed ;30% a-helix, ;25% b-, and ;45% unordered
structures and turns. No signiﬁcant differences were found
between the spectra at 5C and 35C. Finally, the CD spectra
of APP(684–726) incorporated into Sph vesicles were not
interpreted as Sph interfered with the CD signal at wave-
lengths,220 nm. This effect was described before (46). The
spectra resulting from the subtraction of the base line (Sph
liposomes without peptides) were not reproducible in the low
nm range.
Inﬂuence of the lipid environment on the
dynamics of the transmembrane domain
of 2H3-Ala
713-APP(684–726)
To investigate the dynamics of the peptide in the proposed
transmembrane domain, the 2H NMR spectra of 2H3-Ala
713-
APP(684–726) were acquired under low-speed MAS (nr ,
DnQ, where nr is the spinning frequency and DnQ is the
quadrupolar splitting) that allows the characterization of the
quadrupolar interaction through an analysis of the spinning
sidebands intensities. The scaling of the quadrupolar inter-
action can provide information about the dynamics of the
peptide on the microsecond timescale.
The 2H MAS spectrum for the 2H3-Ala
713 of lyophilized
APP(684–726) is shown in Fig. 4 A. The spectrum shows a
large family of sidebands, with the maximum intensity at
620 kHz (ﬁfth sideband). Analysis of the spectrum shows
DnQ ¼ 39.9 6 0.2 kHz with an asymmetry parameter h ¼
0.00 6 0.06, characteristic for a rotating methyl group.
FIGURE 2 Temperature-dependence of the static
31P NMR spectra of different lipid MLV with incorporated
APP(684–726). The transition temperatures Tc are listed in
Table 1. The frequency is given in terms of the chemical
shift relative to 85% H3PO4 at 25C (0 ppm). Spectra of
POPC systems were similar to those of PhC systems and are
not shown.
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The 2H MAS spectra of APP(684–726) reconstituted into
phospholipid vesicles acquired at 5C appeared as a family of
spinning sidebands and a narrow resonance attributed to
DHO (Fig. 4). The spectra of APP(684–726) incorporated in
DMPC, DSPC and Sph bilayers in the Lb phase were similar
to the spectrum of the lyophilized peptide, i.e.,DnQ; 40 kHz
and h 0 (data not shown). Deuterium spectra of APP(684–
726) in PhC and POPC bilayers at 5C also showed signiﬁ-
cant sideband intensities. However, the quadrupolar coupling
constant is somewhat smaller as compared to DMPC, DSPC,
and Sph indicating the presence of additional motion above
those seen in the other lipids analyzed.
Raising the temperature such that the DMPC, DSPC, and
Sph enter their La phase, leads to signiﬁcant changes in the
spectra, with the sideband family collapsing in a way that the
bulk of the intensity is in the central resonance and the in-
tensity of the sidebands decreases rapidly with increasing
sideband order. This is indicative of the presence of signiﬁcant
motions on the microsecond timescale that average the
quadrupolar interaction. Increasing the temperature of the
PhC and POPC systems from 5 to 35C had limited effects on
the spectra. These lipids are in their La phase at both tem-
peratures.
The relatively high DHO signal was assigned to the natural
abundance of deuterium in the buffer components and in the
residual water on the glassware used for the preparation of
the liposomes.
Motional analysis of 15N-Ala692 of APP(684–726)
in different lipid environments
To investigate the effect of lipid bilayer composition on the
dynamics in APP(684–726) close to the a-cleavage site, the
15N CSA of the amide group of Ala692 was investigated in
the low-speed MAS cross-polarization spectra. Fitting the
spectrum of the lyophilized peptide gave an anisotropy of
CSA, d ¼ 97 6 3 ppm and a h ¼ 0.0 (Fig. 5 A).
The 15N MAS spectra of 15N-Ala692-APP(684–726) re-
constituted in lipid vesicles at different temperatures are
shown in Fig. 5 B. On reconstitution into lipid bilayers, the
15N-Ala692 located in the extramembrane part of the peptide
observed more mobility as compared to the 15N-Ala692 of the
lyophilized peptide (Fig. 5 A). Due to the low signal/noise
ratio of the spectra no precise analysis of the corresponding
CSA parameters was possible. However, the simulation of
the 15N tensor for the peptide reconstituted into DMPC at
30C, for instance, indicated a reduced d, with 99 ppm ,
d , 79 ppm (assuming h ¼ 0).
The 15N spectra of APP in PhC, DMPC, and Sph at 5C did
not show any signiﬁcant differences and were similar to the
FIGURE 3 CD analysis of APP(684–726). CD
spectra of APP(684–726) in buffer containing 1%
(v/v) acetonitrile at 37C (A, a) and reconstituted in
DMPC LUVs (A, b), and egg PhC LUVs (B),
measured at 35C (solid lines) and 5C (dashed
lines). (C) CD spectra in DSPC LUVs at 60C (solid
line) and 5C (dashed line). The CD spectrum of the
peptide in buffer containing 1% acetonitrile at 37C
(as in A, a) is included for comparison (gray line).
Shown is the molar ellipticity per residue corrected
for the respective solvent or for the peptide-free
liposomes. (D–F) Multicomponent analysis of the
CD spectra of APP(684–726) in 1% acetonitrile (D)
and after reconstitution in DMPC (E) and DSPC (F)
bilayers at 37C and 60C, respectively. The CD
spectra in A and C were deconvoluted with the
algorithms CONTINLL (black bars), SELCON 3
(light gray bars), and CDSSTR (dark gray bars).
Bars labeled ‘‘unordered’’ include the estimated
percentage of unordered structures and turns.
Shown are data from one representative out of three
independent experiments each.
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respective spectra at higher temperatures. The 15N spectra of
APP(684–726) in DSPC showed a phase-dependent scaling
of the CSA, which suggests a higher mobility of the peptide
ectodomain in the La phase (at 60C) than in the Lb phase
(5C), taking into account the similarity in its conformation
in the two phases as seen in the CD spectra.
Inﬂuence of the lipid environment on the
cleavage by trypsin of reconstituted
FAM-APP(684–726)
Trypsin cleaves APP(684–726) at the a-cleavage site be-
tween Lys687 and Leu688 and is used here as a probe for the
accessibility and cleavability of the a-cleavage site of the
peptide reconstituted in different lipid bilayers. The cleavage
of solubilized FAM-APP(684–726) and of LUV-reconstituted
FAM-labeled peptide was investigated under Michaelis-
Menten conditions. Fig. 6 shows the isocratic HPLC elution
proﬁle of a representative liposomal peptide preparation after
incubation for 5 h with trypsin. FAM-APP(684–687) repre-
sents the main soluble product of the enzymatic digestion
as conﬁrmed by mass spectrometry. The side peaks were not
further analyzed, however, none of them corresponded to
5-carboxyﬂuorescein. The peaks shown in Fig. 6 were neg-
ligible in control experiments without enzyme and immedi-
ately after enzyme addition. After the addition of the enzyme,
the peak areas increased linearly up to 5 h of incubation and
were dependent on the initial FAM-APP(684–726) concen-
tration.
The cleavage velocities v were calculated from the FAM-
APP(684–687) concentrations at the various time points and
were plotted against the initial FAM-APP(684–726) con-
centrations. Fig. 7 A shows the Michaelis-Menten analysis of
the cleavage of solubilized peptide. The Michaelis-Menten
constant KM was ;4 mM when the peptide was solubilized
in buffer containing 1% acetonitrile and ;10 mM at 5%
acetonitrile, respectively. The corresponding Vmax values
were;50 and;70 nmol/min per mg enzyme, corresponding
to kcat values of;0.02 and;0.03 s
1, respectively (Table 2).
In all liposomal systems the peptide was hydrolyzed by the
protease. Fig. 7 B shows the Michaelis-Menten plots for the
release of FAM-APP(684–687) by the proteolytic cleavage
of the peptide reconstituted in DMPC, PhC, Sph, and DSPC
bilayers. No enzyme saturation was observed in the studied
concentration range up to 60 mM in the case of DMPC and
PhC LUVs. Both lipids are in the La phase at 37C and have
a lower hydrophobic thickness than brain Sph and DSPC
bilayers at the same temperature (Table 1). The slope of the v
versus concentration plot corresponds to the enzyme efﬁ-
ciency Vmax/KM of the reaction. The respective values are
listed in Table 2.
Typical Michaelis-Menten saturation kinetics were ob-
served for Sph- and DSPC-reconstituted peptide in the same
concentration range. The Tc of Sph is close to the incubation
temperature, i.e., 35C, Tc of DSPC is at 54.5C (Table 1). In
FIGURE 4 2H NMR MAS spectra of 2H-Ala713-labeled APP(684–
726) with nr ¼ 4 kHz. Spectra of lyophilized peptide in the absence of
lipids (A) and of the peptide reconstituted in MLV of the indicated lipids
at the indicated temperatures (B). The central lines in the spectra of
reconstituted peptide are assigned to residual DHO. Spectra were refer-
enced to DHO.
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contrast to DMPC and PhC these two systems are not or not
exclusively in their La phase at the assay temperature and the
hydrophobic thickness of the bilayers is larger than in DMPC
and PhC membranes. The ﬁtted KM and Vmax values and
the corresponding Vmax/KM values are shown in Table 2.
Although the KM and Vmax values of the examined systems
vary strikingly, Vmax/KM values, i.e., the initial slopes in the
Michaelis-Menten plots in Fig. 7, are within a factor of three.
DISCUSSION
The APP sequence APP(684–726) was reconstituted in lipid
vesicles consisting of different phosphocholine lipids to in-
vestigate the inﬂuence of the lipid bilayer characteristics on
the conformation and dynamics of the peptide and on the
accessibility and cleavability of the a-cleavage site. Solid-
state NMRwith labels in the putative transmembrane domain
and close to the a-cleavage site, CD spectroscopy and en-
zymatic hydrolysis at the a-cleavage site showed that the
lipid acyl chain unsaturation and length have an inﬂuence on
the global secondary structure of the peptide, on the dy-
namics of the transmembrane domain, on the motion of
Ala692 in the vicinity of the a-cleavage site and on the hy-
drolysis kinetics of the a-cleavage site by trypsin.
According to the CD spectra, our model peptide adopts
mainly b-strand and unordered structures in buffer containing
FIGURE 5 15N CP-MAS spectra of lyophilized
and liposome-incorporated 15N-Ala692-labeled APP
(684–726). (A) Superimposition of an experimental
spectrum of lyophilized peptide (scattering lines)
with the ﬁtted 15N MAS spectrum (smooth lines,
details see text). (B) Spectra of the liposome-
reconstituted peptide were recorded at the indicated
spinning speeds and temperatures. Asterisks indi-
cate the spinning sidebands. The frequency is given
in terms of the chemical shift relative to the 15N
signal of glycine at 107 ppm.
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1% acetonitrile and in DSPC bilayers. We did not further
analyze whether the test peptide formed aggregates, proto-
ﬁlament structures or ﬁbrils in buffer. APP(683-699) and
(683-713) corresponding to b-amyloid (12–28) and (12–42),
respectively (47,48), as well as APP(705-713) corresponding
to b-amyloid (34–42) (49) were described to form ﬁbrils.
These sequences (except residue 683) are contained in our
model peptide APP(684–726). When reconstituted in lipo-
somes and analyzed by density centrifugation, all detectable
peptide migrated together with the liposomes, indicating
complete membrane incorporation in all liposomal systems.
Incorporation into DMPC and PhC bilayers induced a
conformational transition reﬂected by the appearance of typ-
ical features of ana-helical structure in the CDmeasurements.
According to the spectra the peptide adopted a stable con-
formation with a-helical and unordered domains in these two
systems. This is in agreement with structure analysis results
of APP or APP fragments. The transmembrane domain is
assumed to form an a-helix (50) and according to structural
prediction algorithms the sequence adjacent to the exofacial
membrane surface does not display any standard secondary
structure (51). Comparison of the CD spectra in DMPC and
PhC showed no signiﬁcant differences in the structural con-
tent. In all three analyzed liposome systems the structure was
independent of the lipid phase (below or above Tc).
FIGURE 6 HPLC separation of the products from the tryptic digestion of
FAM-APP(684–726). Sph liposomes with incorporated peptide were analyzed
after 5 h of incubationwith trypsin. Peaks a,b, c and dwere elutedwithin 20min
and represent the ﬂuorescent products of the digestion. a.u., arbitrary units.
FIGURE 7 Michaelis-Menten kinetic analysis of
the hydrolysis of solubilized and liposome-incorpo-
rated FAM-APP(684–726) to FAM-APP(684–687)
by trypsin. The peptide was solubilized in Tris
buffer, pH 7.4 (A), containing 1% (s and h) or
5% (n) acetonitrile or was reconstituted in lipo-
somes as indicated (B) and subsequently incubated
at different peptide concentrations with trypsin at
37C. The formation of the cleavage product FAM-
APP(684–687) was followed by HPLC and plotted
as a function of the initial FAM-APP(684–726)
concentration. Shown are two to four independent
experiments each (s, h, n, and)).
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Transmembrane peptides reconstituted in lipid membranes
typically undergo fast rotations about the bilayer normal and/
or about the peptide long axis according to the thermotropic
properties of the membrane environment (52,53). 2H NMR
spectroscopy is well-suited to study the dynamic properties
of membrane proteins in phospholipid bilayers (54) with the
quadrupolar splitting and line shapes sensitive to motions on
the microsecond timescale (55,56). The alanine residue at
position 713 of APP(684–726) was deuterated and used as a
nonperturbing probe for the dynamics of the peptide within the
bilayer. In fact, the methyl side chain is a useful probe of
protein dynamics as it is directly attached to the protein back-
bone, thus reﬂecting the motions observed by the peptide in
this region and not just by the amino acid side chains (57).
The mobility of the transmembrane part of APP(684–726)
depended strongly on the phase of the lipids. The 2H spectra
of liposome-incorporated peptide at temperatures,Tc (DMPC,
DSPC, Sph) were similar to the spectrum of lyophilized dry
peptide. The only motion present ,Tc resulted from the
methyl group rotation. A signiﬁcant scaling of the quad-
rupolar interaction was observed at a temperature above or
near the Tc of the investigated lipid indicating an increase in
the density of motion on the microsecond timescale observed
by the APP(684–726) within the bilayer. Such an averaging
of quadrupolar interactions to a few kHz as seen for DMPC
and Sph would be expected if the peptide assumes an
a-helical conformation at the site of Ala713 and it observes
faster rotational motion around the helix axis upon the lipids
transition from the Lb to La phase (52,58,59). Indeed, this is
in agreement with the secondary structural predictions that
suggest the formation of an a-helical transmembrane domain
between residues 700 and 723 (see above) and the presence
of a-helical contributions in the CD spectra of the APP(684–
726) in DMPC. It should be noted, however, that this aver-
aging of the quadrupolar interactions could also be due to the
introduction of a range of different motions or changes in the
conformation of the system.
The scaling of the quadrupolar interaction observed in the 2H
spectra of APP(684–726) in DSPC in the La phase is weaker
than for DMPC. This could be due to a different secondary
structure of APP(684–726) in the two systems, as suggested
by the CD spectra, and/or to different average motions.
Interestingly, on reconstitution into PhC bilayers, which
are in the La phase at all tested temperatures, the quadrupol
interaction was only moderately reduced with respect to the
value for the lyophilized peptide. Similar spectra were ob-
served upon incorporation of APP(684–726) into vesicles
composed of POPC. The incomplete averaging of the quad-
rupol interaction found for the peptide incorporated in bila-
yers composed of unsaturated phosphatidylcholine could
arise through increases in either the radius of the complex or
bilayer viscosity both of which would reduce the rotational
correlation time of the APP(684–726). Saturation-transfer
ESR measurements of integral membrane proteins indicate
that differences between the membrane viscosity of saturated
and unsaturated lipids are small (differing by no more than
a factor of 2) (60). This suggests the differences observed
between the 2H spectra of APP(684–726) in saturated and
unsaturated bilayers may arise from the formation of com-
plexes with a larger radius within the unsaturated bilayer as
compared to the other systems .Tc.
APP contains GlyxxxGly motifs in the putative trans-
membrane region (x stands for any amino acid). In general,
this motif can lead to the dimerization of the respective
transmembrane domain (61). Experiments in cell culture
showed that;50% of the APP is dimerized (62) whereas the
sAPPa truncate, which is the soluble product of a-cleavage,
does not dimerize in solution (51). Dimerization and mono-
merization of APP might be involved in signal transduction
across the membrane (51). Experiments with Gly / Ala
mutants showed that dimerization had no inﬂuence on the
total generation of b-amyloid in cultured cells. However, the
ratios of b-amyloids consisting of 38, 40, and 42 amino acids,
respectively, were signiﬁcantly different in the mutants and
the wild-type cells. The reduction in dimerization by Gly/
Ala mutations resulted in higher ratios of shorter to longer
b-amyloid peptides. No or only minor changes up to 14%
increase, depending on the APP mutant, were observed for
the generation of sAPPa, i.e., for the extent of a-cleavage
(62). Based on these reports, it can be concluded that within
the cell some of the APP dimerizes on the level of the trans-
membrane domain and that this has no inﬂuence on the
accessibility of the a-cleavage site by the a-secretase but
determines the position of g-cleavage.
Our ﬁndings with 2H solid-state NMR and with the tryptic
assay are in agreement with the above. The low amplitude
of the motion of Ala713 observed in the PhC bilayer could be
due to dimerization/oligomerization within the PhC mem-
TABLE 2 Michaelis-Menten parameters of the cleavage by trypsin of FAM-APP(684–726) at the a-cleavage site
System
KM
[mM]
KM9
[mM]*
Vmax [nmol/min]
per mg enzyme kcat [s
1]
Vmax/KM [mL/min]
per mg enzyme
Vmax/KM9 [mL/min]
per mg enzyme
Tris buffer containing 1% acetonitrile 3.51/4.85 — 46.7/49.7 0.018/0.019 13.3/10.2 13.3/10.2 (Vmax/KM)
DMPC liposomes .60 .30 .1000 .0.39 6.1 6 3.4 12.2 6 6.8
PhC liposomes .60 .30 .1000 .0.39 7.7 6 0.8 15.5 6 1.7
DSPC liposomes 36.5/19.9 18.2/10.0 198/189 0.077/0.074 5.4/9.5 10.8/18.9
Sph liposomes 63.9 6 15.9 31.9 6 8.0 918 6 355 0.36 6 0.14 14.3 6 3.1 28.5 6 6.1
Mean values from three independent experiments with SD are shown, except for soluble APP and DSPC with values from two independent experiments.
*KM9 , KM corrected for the estimated fraction of peptide oriented with the cleavage site outside the liposomes (KM9 ¼ KM/2).
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brane. The reduced motion of Ala713 in the PhC membrane
compared to the DMPC membrane had no effect on the hy-
drolysis kinetics in the trypsin assay as the kinetics were
similar for the two systems. If indeed, and this needs further
investigations, the lipid composition dictates the monomer/
dimer equilibrium of the peptide, the membrane environment
of APP could affect the position of g-processing via the ex-
tent of dimerization in the respective membrane environ-
ment. If b-cleaved APP and g-secretase colocalize in a
membrane environment that promotes dimerization, the ratio
of shorter to 42-amino acid b-amyloid, the one that is most
toxic, would be in disfavor for the individual.
The mobility of the amino acid Ala692 of APP(684–726),
which is between the a-cleavage site and the putative trans-
membrane domain, showed a temperature-dependence when
reconstituted in DSPC vesicles. Thus, at the temperature
,Tc, the molecular motion of the
15N site was restricted as
shown by the large CSA compared to that observed in the La
phase. No such inﬂuence of the bilayer phase was observed
with the DMPC system. The difference between the two
systems is the bilayer thickness. The hydrophobic thickness
of DSPC in the Lb phase is 3.6 nm (Table 1) whereas it is
signiﬁcantly less for DMPC and PhC or DSPC in the La
phase. It seems that, without making any assumption on the
structure of APP(684–726) reconstituted into DSPC, the
DSPC bilayer in the Lb phase is thick enough to restrict
the motion of Ala692. The hydrophobic thickness of rafts
was estimated to ;3.6 nm (63). Depending on the lipid
surrounding, variations in the motion and localization of the
a-cleavage site relative to the membrane surface can there-
fore be expected in the cell. This may have an inﬂuence on
the interaction of APP with the a-secretase.
Trypsin was used to probe the accessibility of the amino
acid sequence forming the a-cleavage site of APP. The
peptide concentration was varied by altering the liposome
concentration. The surface density of the peptide was there-
fore constant at all peptide concentrations. Table 3 shows the
characteristics of the liposomal systems in the kinetic assay.
The peptide as well as the number of liposomes was always in
excess of the enzyme. The surface density of the peptide was
such that the average distance between two peptides was
larger than the diameter of the enzyme. As trypsin does not
bind to the surface of PhC liposomes (64), we assume that the
enzyme acts in a ‘‘hopping mode’’ (65), i.e., it leaves the
vesicle surface after one cycle of hydrolysis before it pro-
ceeds with the next hydrolysis cycle with a peptide from the
same or another vesicle. Based on these conditions and on
the assumption that the ratios of outside to inside oriented
a-cleavage sites are similar in all systems, i.e., 1:1, we ap-
plied Michaelis-Menten analysis as for ideal solutions.
In all investigated systems the model peptide was hy-
drolyzed by trypsin between Lys687 and Leu688, i.e., at the
a-cleavage site. However, we observed signiﬁcant differ-
ences in the kinetics of the tested systems. The parameters
KM9 (the observed KM multiplied with 0.5, assuming 50% of
the peptide was oriented with the a-cleavage site on the outer
membrane surface of the liposome) and Vmax were lowest in
solution, intermediate in the systems with Sph and DSPC
membranes and highest with DMPC and PhC.
Finehout et al. (66) reported a KM and kcat for the hy-
drolysis of FITC-casein by trypsin at 37C and pH 7.5 of
2.09 6 0.14 mM and 0.40 6 0.01 s1, respectively. In
comparison, the kcat of the cleavage of FAM-APP(684–726)
in our study was lower in 1% acetonitrile and in DSPC lip-
osomes, i.e.,;0.02 s1 and 0.08 s1, respectively, but was in
the same range in the Sph liposome system and higher in the
DMPC and PhC liposome systems. The Michaelis-Menten
constant KM was similar in solution but was signiﬁcantly
higher in all liposomal systems.
Comparing the kinetic parameters in the tested systems and
assuming Michaelis-Menten conditions, the changes in KM
and Vmax at a similar ratio Vmax/KM is typical for alterations
in the rate of the catalytic step of the reaction, i.e., changes in
the rate constant kcat (42). Indeed, mathematical simulations
of the experimental data were only possible by altering kcat but
not by varying k1 and/or k1 (data not shown). Based on
mechanistic considerations the rate constant kcat depends on
the actual hydrolysis rate and on the release of the shortened
membrane-associated peptide APP(688-726) and the soluble
FAM-APP(684–687), including their replacement by a water
molecule in the active site.
The low kcat values in 1% acetonitrile and in DSPC lipo-
somes may be related to the peptide conformation that was
different from that in DMPC and PhC liposomes as judged
from the CD measurements. In this case, the membrane
characteristics would via their inﬂuence on the peptide con-
formation affect the kinetics of trypsin cleavage.
Alternatively, differences in the micro environment and
particularly in the pH at the position of the enzyme-peptide
complex depending on its distance from the membrane sur-
TABLE 3 Concentrations and molar ratios of enzyme, peptide,
lipids, and liposomes in the cleavage experiments
Enzyme concentration 5 3 1011 M
Peptide concentration 5 3 106 M to 6 3 105 M
Lipid concentration 5 3 104 M to 6 3 103 M
Lipids per liposome 2 3 105 (assuming a sphere with
150 nm diameter)*
Average number of peptides
per liposome
2000 (at a lipid/peptide ratio
of 100)
Average distance between
two peptides
6 nmy
Diameter of the enzyme 4 nmz
Vesicle concentration 3 3 109 M to 3 3 108 M{
Enzyme/peptide (M/M) 1/105 to 1/106
Enzyme/vesicle (M/M) 1/60 to 1/600
*Calculated with an average surface area of 0.7 nm2 per lipid (79).
yCalculated from the average liposome surface area and the average
number of peptides per liposome.
zDiaz and Balkus (80).
{Calculated from the average outer vesicle surface, the average lipid surface
area, and the lipid concentration.
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face could affect the hydrolysis rate. The KM for the hy-
drolysis of FITC-labeled calcein by the modiﬁed trypsin was
pH-dependent in a range between pH 7.0 and 8.6 (66).
However, kcat only varied between 0.32 6 0.01 and 0.44 6
0.01 s1 in the same pH range. Any slight differences in pH
at the positions where hydrolysis takes place in our systems
are therefore not expected to cause the observed variations in
Vmax and kcat.
Regarding the release of the products from the active site,
we do not expect a direct inﬂuence of the bilayer, however,
the residence time of the enzyme at the membrane surface
could be dependent on the characteristics of the bilayer. The
catalytic rate (kcat) was faster in the systems with the thinner
bilayers (DMPC and PhC) than in those with the thicker
bilayers (DSPC and Sph). One possibility is that the enzyme
interacts with the membrane surface, depending on the dis-
tance of the cleavage site from the surface. When interacting
with the peptide incorporated in the thicker membranes, the
enzyme may sense an intimate contact with the surface,
forming hydrogen bonds and ionic interactions. It may need
more energy and time to detach from the cleaved peptide and
the membrane surface than the enzyme cleaving a peptide
reconstituted in a thinner membrane. In other words, the
hopping rate is slower with the thicker than with the thinner
membranes, leading to the observed differences in kcat.
Based on our data we can not conclude whether the
membrane characteristics affect the hydrolysis kinetics via
their inﬂuence on the peptide conformation or via their in-
ﬂuence on the distance of the a-cleavage site from the
membrane surface. Trypsin was used in our study as a probe
for the accessibility and cleavability of the a-cleavage site.
We do not expect that the kinetics of hydrolysis catalyzed
by a-secretase would show the same characteristics as we
found with trypsin. However, based on our results from the
15N-NMR analysis and from the tryptic cleavage assay, we
conclude that the membrane thickness inﬂuences the motion
and disposition of the a-cleavage site. This could have an
inﬂuence on its recognition and processing by a-secretase.
On the cellular level the generation of b-amyloid was
found to occur in cholesterol-rich, detergent-resistant mem-
brane domains, also called rafts, and was reduced by the
treatment of the cells with statins, which inhibit the biosyn-
thesis of cholesterol (67–69). In addition, cholesterol deple-
tion by b-methyl cyclodextrin of cells and inhibition of
cholesterol biosynthesis with statins, increased the products
of a-cleavage (15). The activity of a-secretase was related to
the membrane ﬂuidity. Membrane ﬂuidization by cholesterol
depletion enhanced the a-secretase activity whereas choles-
terol replacement by sterols lacking membrane-rigidifying
effects did not reduce the a-secretase activity (15). Consid-
ering our ﬁndings, it will be interesting to see whether beside
the membrane ﬂuidity also the membrane thickness has an
inﬂuence on the a-cleavage in cultured cells.
It has been hypothesized that the nonamyloidogenic pro-
cessing of APP, i.e., a-cleavage, occurs outside rafts (70). In
HEK cells, ADAM 10 was mainly localized in detergent
soluble domains and only a small fraction of ADAM 10
proform was found in rafts (15). Also ADAM 17, another
enzyme with suggested a-secretase activity, was localized in
nonraft fractions (71). According to (19) APP is protected
from b- and g-cleavage by the separation of the respective
enzymes into rafts whereas APP resides in detergent-soluble
membrane domains. Based on our study it may be that not
only the physical separation of APP and a-secretase from the
b- and g-secretase plays a role for the processing of APP but
also the membrane environment of APP in that it inﬂuences
its properties as a substrate for a- and g-secretase, respec-
tively.
In conclusion, the rotational motion of the transmembrane
domain of the model peptide APP(684–726) is reduced in
phosphatidylcholine bilayers with unsaturated acyl chains as
compared to bilayers consisting of saturated lipids (.Tc) at a
similar or larger membrane thickness. This may indicate
that peptide dimerization or oligomerization is dependent
on the properties of the membrane hydrophobic core. The
membrane thickness on the other hand affected the dynamics
of the a-cleavage site as well as the kinetics of its tryptic
cleavage. Extrapolated to the in vivo situation, the non-
amyloidogenic processing of APP may be affected by the
lipid environment of the protein.
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